The Adobe Flash Player is required to view this multimedia interactive. Get it here.

Amylin drug now available

Area bank sees rising debit card fraud
11:52 a.m.
Coalition: UAS conference to return to Dayton in 2013
11:48 a.m.
Most job openings in health care, retail, trucking
11:20 a.m.
Sales tax revenues continue upward trajectory
11:19 a.m.
Beach Waterpark sued for failure to deliver
12:25 p.m.
> More headlines

Staff Report 11:49 AM Tuesday, February 14, 2012

WEST CHESTER TWP. — The first once-weekly treatment for type 2 diabetes in the U.S. made by Amylin Pharmaceuticals is now available by prescription, the company announced.

The U.S. Food and Drug Administration approved Bydureon Jan. 27. Bydureon is produced locally at Amylin’s West Chester Twp. manufacturing plant on Trade Port Drive.

San Diego, Calif.-based Amylin started operating in 2009 its local manufacturing plant, which employs approximately 300 people.

Share this article